Suchergebnisse - "Held, Gerhard"

PubPharm (12)

1

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia

enthalten in: Haematologica | 2023

von Kayser, S. | Martínez-Cuadrón, D. | Rodriguez-Veiga, R. | +29

2

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2022

von Goldschmidt, H. | Mai, E. | Bertsch, U. | +123

CommentIn: Lancet Haematol. 2022 Nov;9(11):e798-e799. - PMID 36328036

3

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL>60 trials

enthalten in: European journal of nuclear medicine and molecular imaging | 2021

von Kaddu-Mulindwa, D. | Altmann, B. | Held, G. | +16

4

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2019

von Poeschel, V. | Held, G. | Ziepert, M. | +43

CommentIn: Lancet. 2020 Dec 21;394(10216):2208-2209. - PMID 31868615

5

Optimization of rituximab for the treatment of DLBCL : increasing the dose for elderly male patients

enthalten in: British journal of haematology | 2017

von Pfreundschuh, M. | Murawski, N. | Zeynalova, S. | +16

6

Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation

enthalten in: Blood | 2014

von Schlenk, R. | Kayser, S. | Bullinger, L. | +23

CommentIn: Blood. 2014 Nov 27;124(23):3341-2. - PMID 25431476

7

Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Bittenbring, J. | Neumann, F. | Altmann, B. | +7

8

The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas

enthalten in: Blood | 2014

von Murawski, N. | Held, G. | Ziepert, M. | +12

9

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients

enthalten in: Blood | 2014

von Tassara, M. | Döhner, K. | Brossart, P. | +22

ErratumIn: Blood. 2015 May 7;125(19):3037

10

TET2 mutations in acute myeloid leukemia (AML) : results from a comprehensive genetic and clinical analysis of the AML study group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Gaidzik, V. | Paschka, P. | Späth, D. | +13